A detailed history of Tap Consulting, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Tap Consulting, LLC holds 3,125 shares of DXCM stock, worth $243,125. This represents 0.04% of its overall portfolio holdings.

Number of Shares
3,125
Previous 3,125 -0.0%
Holding current value
$243,125
Previous $354,000 40.96%
% of portfolio
0.04%
Previous 0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Dec 05, 2023

SELL
$86.06 - $137.93 $6,454 - $10,344
-75 Reduced 2.34%
3,125 $291,000
Q2 2022

Jul 26, 2022

BUY
$67.99 - $132.89 $163,176 - $318,935
2,400 Added 300.0%
3,200 $238,000
Q3 2020

Oct 20, 2020

SELL
$95.51 - $112.95 $477 - $564
-5 Reduced 0.62%
800 $330,000
Q2 2020

Aug 11, 2020

BUY
$62.68 - $105.34 $313 - $526
5 Added 0.63%
805 $326,000
Q1 2020

Apr 29, 2020

BUY
$47.79 - $75.63 $38,232 - $60,504
800 New
800 $215,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $30.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Tap Consulting, LLC Portfolio

Follow Tap Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tap Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tap Consulting, LLC with notifications on news.